Scientific Updates for the Psychedelics Industry

Psychedelics News

Science

6 May 2024

Innovating CNS Disorder Treatment: EQUULUS and the Revolutionary Approach with Analog Ibogaine

Navigating the complex landscape of pharmaceutical development for central nervous system (CNS) disorders is no small feat. Current treatments vary widely, from antipsychotics to antidepressants and mood stabilizers. However, for...

By Madison Roberts

Science

3 May 2024

Ketamine-Assisted Psychotherapy for Chronic Pain and Depression

Chronic pain and depression are major health crises in the United States, significantly affecting the quality of life for millions. Traditional treatments often fall short in providing relief, leading to...

By Madison Roberts

Science

1 May 2024

Harnessing Ketamine for Complex Psychiatric Cases: A Dual Diagnosis Approach

In the rapidly evolving landscape of psychiatric care, innovative treatments like ketamine assisted psychotherapy (KAP) hold promise for addressing complex, comorbid conditions that traditional therapies often struggle to manage....

By Madison Roberts

Science

26 Apr 2024

The Tiny Dose That Gave A Big Sleep

A new study published in Nature Translational Psychiatry reveals that microdosing the psychedelic drug LSD causes people to sleep longer the next night. Could better sleep unlock some of microdosing's...

By Madison Roberts

Join Our Newsletter for Exclusive Updates, Stories, and More

Science

27 Nov 2023

New Study Looks at Shame, Guilt and the Psychedelic Experience

A new study looks at emotionally painful, shame-related processes with psychedelic use....

By Microdose NewsDesk

Science

13 Oct 2023

FDA Issues Warning Letter for Ketamine

The FDA has issued a warning letter regarding the use of ketamine outside of FDA-approved conditions....

By Jason Najum

Science

11 Oct 2023

New Study Shows Microdoses Reduce Compulsive Behavior (in rats)

A new study in rodents shows that low doses of psilocybin increase resilience to stress and lower compulsive actions....

By Jason Najum

Science

6 Oct 2023

New Study Shows Spravato Effective When Combined With SSRIs

A new study published in the New England Journal of Medicine found that Spravato’s esketamine was more effective than a commonly prescribed drug in treating treatment-resistant depression....

By Jason Najum

Science

26 Sep 2023

Positive Data from Small Pharma’s New Study Combining DMT & SSRIs

Topline results from Small Pharma's Phase Ib study exploring the interaction between SSRIs and SPL026, the company’s DMT drug....

By Jason Najum

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result